Cryoport, Inc. CYRX R2K

Q: What is the current share price of Cryoport, Inc. (CYRX)?

As of 2026-07-14 21:23 PDT, Cryoport, Inc. (CYRX) trades at $16.07 on NasdaqCM. Its 52-week range is $6.71 to $16.50.

Q: What is the market capitalisation of CYRX?

Cryoport, Inc. (CYRX) has a market capitalisation of $809.97M on NasdaqCM.

Q: What is the P/E ratio of CYRX?

CYRX trades at a trailing price-to-earnings (P/E) ratio of -17.86. The industry average P/E is 30.17. Its price-to-book (P/B) ratio is 1.63.

Q: What is the return on equity (ROE) of CYRX?

CYRX has a return on equity (ROE) of -8.20%. Its return on capital employed (ROCE) is -6.74%.

Q: Is CYRX a good stock to buy?

This page provides a data-driven analysis of Cryoport, Inc. (CYRX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Industrials · Integrated Freight & Logistics · United States

https://www.cryoportinc.com

Company Profile ↓

$16.07

+114.27% 1Y

Mkt Cap$809.97M

P/E-17.86

P/B1.63

52W High$16.50

52W Low$6.71

Book Value$8.98

EPS (TTM)$-0.90

Company Overview

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 48.3% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 43.6%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $176.18M (+12.4% YoY); net profit $78.30M.
Trailing 12 Months Year-on-year growth — revenue +16.5%.
5-Year Trend Long-term compounding — revenue CAGR 48.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	48.34%
1 Year:	16.50%

Stock Price Performance

1 Year:	+114.27%
6 Months:	+52.18%
3 Months:	+66.70%
1 Month:	+11.75%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish

52-Week Range 96% of range

$6.71 $16.50

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
RSI (14)59.61 · Neutral

Price Performance

1M+11.75%

3M+66.70%

6M+52.18%

1Y+114.27%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Excellent profit margin of 43.6%.
Compounding revenue at 48.3% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-17.86

Industry PE

30.17

Forward P/E

-25.92

PEG Ratio

62.13

Book Value

$8.98

Price to Book

1.63

P/S

4.03

EV/EBITDA

-254.72

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

48.34%

Profit 5Y

Revenue (YoY)

16.50%

Earnings (YoY)

Profitability & Returns

ROCE

-6.74%

ROE

-8.20%

ROA

-2.46%

Profit Margin

43.59%

Op Margin

-20.08%

Gross Margin

47.19%

EPS (Latest Qtr)

$-0.25

EPS (TTM)

$-0.90

Balance Sheet & Liquidity

Debt/Equity

0.47

Quick Ratio

1.97

Current Ratio

2.09

Debt

$230.49M

Total Assets

$763.61M

Current Assets

Working Capital

Ownership

Promoter Holding

3.93%

Chg in Prom Hold

FII / Inst Holding

96.79%

Chg in FII Hold

-0.08%

Financial Snapshot

Enterprise Value

$809.97M

Total Revenue (TTM)

$182.94M

EBITDA

$-2.39M

Free Cash Flow

$64.53M

Operating Cash Flow

$-503.00K

Shares Outstanding

50.40M

Gross Margin

47.19%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Industrials).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	CYRX Cryoport, Inc. R2K	16.07	-17.86	$809.97M	0.00%	-6.74%	-8.20%	48.34%	-
2	CAT Caterpillar Inc. SPX	933.34	46.39	$429.89B	0.72%	17.98%	51.33%	2.29%	5.24%
3	GE GE Aerospace SPX	353.73	43.94	$369.06B	0.56%	11.89%	45.43%	16.32%	195.89%
4	GEV GE Vernova Inc. SPXAI	1,066.01	31.13	$286.46B	0.21%	6.30%	75.71%	8.68%	-
5	RTX RTX Corporation SPX	193.39	36.35	$260.44B	1.51%	8.28%	11.57%	2.61%	2.62%
6	UNP Union Pacific Corporation SPX	288.30	23.71	$171.17B	2.02%	15.22%	40.69%	2.30%	7.77%
7	BA The Boeing Company SPX	217.11	86.15	$171.15B	0.00%	-9.01%	-	1.67%	-3.28%
8	ETN Eaton Corporation plc SPXAI	415.52	40.66	$161.35B	1.12%	11.53%	20.84%	4.73%	10.38%
9	DE Deere & Company SPX	584.40	33.07	$157.85B	1.12%	-	18.35%	3.43%	5.10%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37.29M	39.71M	38.32M	41.04M	45.45M	44.23M	47.80M
Gross Profit	436.31K	384.00K	0	782.00K	797.00K	941.00K	1.25M	1.39M	1.61M	1.71M	2.18M	2.50M	2.74M	2.82M	3.45M	4.34M	4.63M	4.93M	5.26M	5.13M	6.05M	19.89M	24.55M	25.40M	23.51M	23.11M	22.34M	28.84M	26.42M	26.28M	27.07M	24.73M	24.27M	15.06M	17.66M	17.44M	18.64M	21.38M	21.32M	21.91M
Operating Income	-1.82M	-2.68M	0	-1.98M	-2.16M	-2.00M	-1.77M	-1.86M	-1.99M	-2.27M	-1.80M	-2.46M	-2.16M	-2.22M	-2.14M	-2.30M	-12.35M	-878.00K	-3.59M	-5.84M	-10.73M	-9.85M	-1.14M	-3.75M	-4.58M	-8.36M	-7.82M	-5.25M	-7.80M	-11.04M	-10.04M	-18.33M	-16.91M	-17.51M	-78.03M	-13.39M	-7.19M	-9.65M	-9.93M	-9.61M
Net Income	-2.43M	-2.76M	0	-3.94M	-2.18M	-4.28M	-1.79M	-1.86M	-1.98M	-2.27M	-2.68M	-2.47M	-2.14M	-2.26M	-2.39M	-2.53M	-12.47M	-948.00K	-3.94M	-5.80M	-11.42M	-	-3.53M	-5.39M	-6.53M	-	-13.40M	-9.18M	-5.32M	-	-5.57M	-18.36M	-13.27M	-18.89M	-77.99M	805.00K	-11.98M	105.18M	-6.94M	-10.54M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.11	-0.15	-0.29	-1.32	-0.13	-0.16	-0.18	-5.46	-0.31	-0.23	-0.15	-0.24	-0.16	-0.42	-0.31	-0.43	-1.62	-0.02	-0.28	2.05	-0.18	-0.25
R&D Expense	100.30K	227.76K	144.48K	135.80K	214.68K	-	249.84K	230.74K	344.80K	-	329.73K	448.59K	463.36K	-	489.60K	540.93K	1.64M	-	1.73M	1.95M	2.31M	-	4.30M	4.46M	4.19M	-	3.54M	3.52M	3.98M	-	3.88M	4.26M	5.15M	4.75M	4.65M	4.16M	3.93M	4.12M	4.52M	3.91M

Profit & Loss (Annual)

Figures in USD.

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	475.50K	555.64K	1.10M	2.66M	3.94M	5.88M	7.68M	11.95M	19.63M	33.94M	78.70M	222.61M	237.28M	168.66M	156.77M	176.18M
Gross Profit	-827.48K	-836.82K	-487.28K	436.95K	1.17M	1.89M	3.10M	5.97M	10.24M	17.35M	36.33M	96.58M	103.87M	75.33M	69.66M	83.05M
Operating Income	-5.60M	-7.43M	-6.32M	-5.08M	-5.59M	-8.74M	-8.77M	-7.89M	-8.64M	-17.68M	-30.01M	-17.83M	-31.90M	-100.54M	-121.67M	-36.81M
Net Income	-6.15M	-7.83M	-6.38M	-19.57M	-7.03M	-9.82M	-13.11M	-7.90M	-9.56M	-18.33M	-32.69M	-275.53M	-37.33M	-99.59M	-114.76M	78.30M
Diluted EPS	-	-	-	-	-	-	-	-	-	-0.55	-1.94	-6.18	-0.93	-2.21	-2.49	1.40
R&D Expense	449.13K	491.85K	425.45K	409.11K	352.58K	550.26K	598.11K	1.21M	1.84M	3.74M	9.48M	16.84M	15.72M	18.04M	17.71M	17.04M

Balance Sheet (Annual)

Figures in USD.

Metric	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Dec 2015	Mar 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	11.03M	6.21M	1.76M	1.71M	2.61M	-	5.82M	8.11M	20.26M	56.62M	135.87M	552.40M	1.11B	1.04B	957.74M	703.49M	764.99M
Total Equity	-914.58K	5.95M	3.73M	-2.06M	-2.30M	-416.30K	-	3.10M	5.68M	17.89M	38.55M	126.28M	382.70M	641.83M	555.84M	489.02M	401.90M	502.64M
Cash & Equivalents	3.63M	9.28M	4.62M	563.10K	369.58K	1.41M	5.25M	2.79M	4.52M	15.04M	37.33M	47.23M	36.87M	139.10M	29.23M	35.19M	34.14M	250.49M
Long Term Debt	-	-	325.32K	1.29M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	5.08M	2.48M	3.82M	4.01M	3.02M	-	2.73M	2.43M	2.38M	18.07M	9.59M	169.71M	471.14M	482.91M	468.72M	301.59M	262.35M
Current Liabilities	-	3.24M	1.11M	2.50M	4.01M	3.00M	-	2.17M	2.23M	2.20M	3.06M	5.46M	35.02M	42.65M	40.85M	45.61M	64.56M	219.02M

Cash Flows (Annual)

Figures in USD.

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-4.81M	-6.78M	-4.79M	-	-	-	-5.72M	-3.58M	-3.35M	-1.32M	-14.87M	8.13M	-1.85M	-757.00K	-16.32M	-8.58M
Investing Cash Flow	-465.45K	-388.06K	-178.68K	-	-	-	-1.07M	-1.80M	-12.88M	-62.93M	-382.31M	-469.25M	-59.68M	36.05M	176.81M	250.32M
Financing Cash Flow	10.93M	2.51M	909.39K	-	-	-	6.06M	15.90M	38.53M	74.15M	385.58M	564.34M	-39.17M	-23.80M	-161.53M	-21.07M
Capital Expenditure	-341.40K	-262.64K	-156.20K	-138.89K	-70.13K	-1.12M	-1.06M	-1.71M	-2.91M	-5.34M	-8.92M	-23.88M	-22.11M	-38.78M	-17.25M	-16.44M
Free Cash Flow	-5.15M	-7.04M	-4.94M	-	-	-	-6.78M	-5.30M	-6.27M	-6.66M	-23.78M	-15.76M	-23.96M	-39.54M	-33.58M	-25.02M
Share Buybacks	-	-	-	-	-	-	-	-	-	-	0	0	37.96M	-	-	10.01M

Ratios (Annual)

Figures in %.

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-174.0%	-150.6%	-44.3%	16.4%	29.7%	32.1%	40.4%	49.9%	52.2%	51.1%	46.2%	43.4%	43.8%	44.7%	44.4%	47.1%
Operating Margin %	-1,177.1%	-1,338.0%	-574.7%	-190.9%	-142.1%	-148.6%	-114.2%	-66.0%	-44.0%	-52.1%	-38.1%	-8.0%	-13.4%	-59.6%	-77.6%	-20.9%
Net Margin %	-1,293.8%	-1,409.7%	-579.9%	-735.6%	-178.6%	-167.0%	-170.8%	-66.1%	-48.7%	-54.0%	-41.5%	-123.8%	-15.7%	-59.0%	-73.2%	44.4%
ROE %	-103.4%	-210.0%	309.3%	849.0%	1,687.9%	-317.2%	-230.9%	-44.2%	-24.8%	-14.5%	-8.5%	-42.9%	-6.7%	-20.4%	-28.6%	15.6%
ROCE %	-71.8%	-145.6%	852.8%	220.4%	1,434.7%	-239.5%	-149.1%	-43.7%	-16.1%	-13.6%	-5.8%	-1.7%	-3.2%	-11.0%	-19.0%	-6.7%

Shareholding Pattern

Insiders

3.93%

Institutions

96.79%

Public Float

100.76%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Cadian Capital Management, LP	9.48%	4.78M	$73.46M
2	Morgan Stanley	9.08%	4.58M	$70.39M
3	Blackrock Inc.	7.90%	3.98M	$61.23M
4	Millennium Management Llc	5.89%	2.97M	$45.69M
5	Vanguard Capital Management LLC	4.20%	2.12M	$32.59M
6	Fred Alger Management, LLC	3.37%	1.70M	$26.14M
7	Assenagon Asset Management S.A.	2.97%	1.50M	$23.00M
8	MAK Capital One LLC	2.82%	1.42M	$21.89M
9	Geode Capital Management, LLC	2.48%	1.25M	$19.20M
10	Mirova	2.30%	1.16M	$17.81M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CYRX

Google News Mon, 13 Jul 2026

SG Americas Securities LLC Cuts Stock Holdings in CryoPort, Inc. $CYRX - MarketBeat

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNOHR3NzhaUDBkVGJkSkJmczNZZ21hYml6aThpRUNTYjlUcUhFZmhmSE54ZVJaTEJyWVFmQjJ1ZnhsM2NQUDNZR1FDMnk2b2FKN2pjZEJsVm0zczd4dVJENmswbUwxSnhJaE1fdTd1ZHBMOG5OUm5PVnA2cVZGMlZrZkl0OGFZN1lyYU9sbG…

Google News Sat, 13 Jun 2026

Cryoport (CYRX) Stock Fair Value Rises After Analysts Revisit Bioservices Outlook - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPd1E1Qm9PRjBRcFo4bnE3WEJETllqUzgxQ2lzNjIzSkhQQWhpRkN4Njc3V1VLNEdyLU1PUERSLWJmQi1JU05TR3pvdHRPSmxfRXVRbzJyTmxfaVJzNmRRQWpJajhGOHJRc2Vtd2RVTmpqRWxFUW5wcDJMNEJLQktVRy02VEtsRmkzNlRDUT…

Google News ue, 14 Jul 2026

(CYRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNNWswXzZQVndHQmUxRkZydTVoRkFJeEZJVXRUNFNYTTE2REF3T2NTVUVHdUNFUDhESVJ0R2Z1Y2RQV1NIVDF4N0Zkcnc5RFhfYkxKbzFMTnlyU25CWFFEZXFvcVlpWl9pdE1fc2plNV9CcllnNTJRZUJOaURCei1jWHNGV0hPZ1dZMjV2b0…

Google News hu, 25 Jun 2026

Cryoport lands Verismo for clinical cell therapy cryopreservation - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPS1FmRFVqNWY5MHFvYVFoQUxlYlVsRlU3WHFweVBrUmR1UGVtLVAyS3pOWkNweW95VWZELTB0M1p1TDMtQTFCSVBEVmFWWDVlaE5QYlk4MmdOS0puNTRXUlJlVmxFa2tkZWgxZl85Tk1uaTFBUXB6NC1sdjB4aUttZXhvUU44WmZUb0R5eH…

Google News Mon, 04 May 2026

Cryoport Reports First Quarter 2026 Financial Results - PR Newswire

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOZmRGa0RZaDYxSHpBMTdOSnNYZE43WGZWNXlfVEVrTnRCZmo2dnRIbDVDT3JkVnhsb001WXg5NzJ3dHRGbG1fb0k2bFNLY3lpMWtPM0ZFanZ3TldMWWoyd0J1c0V6b1ZKT0pfenpXTU5MbENPWVNEQ3ZoSmlaRVc3elhzTlRORVlpSW1yaH…

Google News ue, 03 Mar 2026

CryoPort Inc. (CYRX) Stock Rises on Q4 2025 Earnings - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxNV3hMRk5scWFDcTd3ZWZrT1g4aWxCVWlHNWgyYTg0bFg1VFRaeEF4QWUwanhDclZIWTFCRDdhOVJPYkl5UjA1eUdEaDlMXzF5aVRSbjJvMWlCU1VEMmJRRmdNdTR4TzV4djlHMVlCN0tjTk5QOVphTzJfcFRoVFFkMTVaRGdHeUhDdUl6WU…

CYRX — Frequently Asked Questions

What is the current share price of Cryoport, Inc. (CYRX)?

As of 2026-07-14 21:23 PDT, Cryoport, Inc. (CYRX) trades at $16.07 on NasdaqCM. Its 52-week range is $6.71 to $16.50.

What is the market capitalisation of CYRX?

Cryoport, Inc. (CYRX) has a market capitalisation of $809.97M on NasdaqCM.

What is the P/E ratio of CYRX?

CYRX trades at a trailing price-to-earnings (P/E) ratio of -17.86. The industry average P/E is 30.17. Its price-to-book (P/B) ratio is 1.63.

What is the return on equity (ROE) of CYRX?

CYRX has a return on equity (ROE) of -8.20%. Its return on capital employed (ROCE) is -6.74%.

Is CYRX a good stock to buy?

This page provides a data-driven analysis of Cryoport, Inc. (CYRX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Industrials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Cryoport, Inc. CYRX R2K

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

SG Americas Securities LLC Cuts Stock Holdings in CryoPort, Inc. $CYRX - MarketBeat

Cryoport (CYRX) Stock Fair Value Rises After Analysts Revisit Bioservices Outlook - Yahoo Finance

(CYRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Cryoport lands Verismo for clinical cell therapy cryopreservation - Stock Titan

Cryoport Reports First Quarter 2026 Financial Results - PR Newswire

CryoPort Inc. (CYRX) Stock Rises on Q4 2025 Earnings - Quiver Quantitative

CYRX — Frequently Asked Questions

What is the current share price of Cryoport, Inc. (CYRX)?

What is the market capitalisation of CYRX?

What is the P/E ratio of CYRX?

What is the return on equity (ROE) of CYRX?

Is CYRX a good stock to buy?

Explore More